Entia Biosciences (ERGO) 8-K Entry into a Material Definitive Agreement

Exhibit 10.1

December 26th, 2014

Arthur C. Piculell Jr. and Marvin S. Hausman, CEO Entia Biosciences Inc. hereby extend Exhibit A attached hereto and made a part hereof as if fully set out herein.

1.    This agreement will be extended for one year from the above date with the interest rate of 8% from the original date of note August 13, 2013.

2.   In addition thereto Arthur C. Piculell Jr. will also receive a 5 year warrant for 50,000 shares with an exercise price of 50 cents.  This warrant shall have a cashless exchange provision.

3.   All other terms shall remain the same as set forth in Exhibit A.

/s/ Marvin S. Hausman                                                                          Dated:  January 10, 2015

Marvin S. Hausman, CEO Entia Biosciences Inc.

/s/ Arthur C. Piculell Jr.                                                                          Dated:  January 10, 2015

Arthur C. Piculell Jr.